PF-Atlas › Clinical Trials › NCT03800017
Skeletal Muscle Function in Interstitial Lung Disease
Hyperoxia · Not specified
Registry ID
NCT03800017
Phase
Not specified
Status
Recruiting
Drug / intervention
Hyperoxia
Sponsor
University of British Columbia
Start
2024-08-07
Enrollment
40
Locations
1
About this trial
Dyspnea (i.e. breathlessness) and exercise intolerance are common symptoms for patients with interstitial lung disease (ILD), yet it is not known why. It has been suggested that muscle dysfunction may contribute to dyspnea and exercise intolerance in ILD. Our study aims to: i) examine differences in the structure and function of the leg muscles in ILD patients, ii) determine if leg muscle fatigue contributes to dyspnea and exercise limitation in patients with ILD, and iii) determine the effects of breathing extra oxygen on leg muscle fatigue, as well as ability to exercise in ILD patients.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03800017 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.